Speaker Dr. Cristiana Tresoldi
In this session, Dr. Tresoldi delves into the crucial role of molecular biomarkers in the diagnosis and management of Chronic Myeloid Leukemia (CML), showcasing how optimized molecular testing strategies can enhance diagnostic accuracy, enable deep response monitoring, and improve overall disease management.